Activation of the prolactin/Jak2 signaling pathway in mesenchymal-like breast cancer cells suppressed their mesenchymal properties and reduced their invasive behavior while blocking prolactin autocrine function in epithelial-like breast cancer cells induced mesenchymal-like phenotypic changes and enhanced their invasive capacity [278]. The gene discussed is JAK2; the disease is breast cancer.